CMO CMOs in 2025 – 6 Trends Reshaping Pharma Manufacturing Pharma industry is evolving fast. CMOs are now strategic partners, not just service providers. From resilient supply chains to digital workflows to ESG, six trends are reshaping the development and manufacturing in the pharma industry.
CDMO CRO vs CMO vs CDMO – Selecting the Right Partner Explore the differences between CROs, CMOs, and CDMOs to find the right pharma outsourcing partner. Discover how each supports drug development from research to manufacturing, and how Scimplify can streamline your journey.
Pharma Industry Indian Pharma 2050 – Five Tailwinds Powering the $450 Billion Vision India has rightly earned its place as the “pharmacy of the world.” But how will the Indian pharma industry evolve from just being a manufacturing-driven center to a global innovation powerhouse? The answer lies in five powerful tailwinds.
Pharma Industry From Diabetes to Weight Loss – The Accidental Rise of GLP-1 Drugs A few diabetes drugs to help blood sugar levels, fundamentally forms of GLP-1 receptor agonists like Ozempic, Mounjaro, and Wegovy, among others, have accidentally become the most sought-after weight loss medications.
Chemical Research Beyond Gravity – How Space Research is Revolutionizing Pharmaceuticals Space research is probably one of the most complex and exciting frontiers of a progressing human civilization. It has always been more than just exploring the uncharted worlds but also about making life here, on planet Earth, a better one. By continuously expanding the boundaries of science and technology for
Pharmaceutical Manufacturing Choosing the Right CDMO for Your Business – A Few Key Considerations In today’s fiercely competitive pharmaceutical industry, the pressure to innovate and deliver breakthrough therapies has never been greater. With tight budgets and deadlines, and often a lack of in-house expertise and capabilities, businesses are increasingly partnering with Contract Development and Manufacturing Organizations (CDMOs) for comprehensive support. CDMOs offer end-to-end
CDMO U.S. Biosecure Act – Fueling Opportunities for India’s Pharma CDMOs The global pharmaceutical landscape is experiencing a monumental transformation, fueled by the newly enacted U.S. Biosecure Act. This pivotal legislation seeks to bolster national security by preventing U.S. companies from engaging with foreign biotech firms that pose risks through unauthorized data sharing and affiliations with adversarial military or
